Last reviewed · How we verify
NCT07280416: INDICA
Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer
trial in Cancer in 260 participants. Currently enrolling.
1 November 2028
Quick facts
| Lead sponsor | Centre Hospitalier Emile Roux |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 260 |
| Start date | 16 December 2025 |
| Primary completion | 1 November 2028 |
| Estimated completion | 1 November 2028 |
| Sites | 1 location across France |
Conditions studied
- Cancer — all drugs for Cancer →
- Insomnia — all drugs for Insomnia →
- Pain — all drugs for Pain →
- Depression Anxiety Disorder — all drugs for Depression Anxiety Disorder →
Sponsor
Centre Hospitalier Emile Roux
Who can join
Adults 18 to 80, any sex, with Cancer or Insomnia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The diagnosis of cancer can be a major trigger for new sleep problems, especially insomnia, in people who did not have sleep issues before. Insomnia may appear early in the care pathway and can continue over time, often interacting with other physical or emotional symptoms. The main goal of this preliminary study is to describe how insomnia develops during the first months after a cancer diagnosis in patients who had no sleep problems at the time of diagnosis. This will be done through regular follow-up over time. A secondary aim is to identify the factors that may contribute to the onset or persistence of insomnia, such as the cancer treatments patients receive, as well as any medical or non-medical therapies used to manage sleep difficulties. The study will also look at whether patients who develop sleep problems are referred to psychologists trained in specific therapies for insomnia, and how well they follow and adhere to these treatments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07280416
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Centre Hospitalier Emile Roux trials
Trials by the same sponsor.
- NCT07134023 — Educational Program for the Multidisciplinary Support of Patients With Endometriosis · NA · recruiting
- NCT07233109 — Energy Expenditure and Neuromuscular Function in Young Adult Women With a Naturally Thin Build (LeanErgy) · NA · not yet recruiting
- NCT07233174 — Postprandial Thermogenesis in Obese Adolescents: Effect of Meal Calorie Content · NA · completed
- NCT06708338 — Impact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis · NA · not yet recruiting
- NCT07155746 — Effect of Simulated Weight Loss on the Energy Cost of Locomotion in Overweight or Obese Adolescents · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07280416 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Emile Roux
- Last refreshed: 11 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07280416.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing